Skip to main content
. Author manuscript; available in PMC: 2022 Sep 30.
Published in final edited form as: Cell. 2021 Sep 16;184(20):5247–5260.e19. doi: 10.1016/j.cell.2021.08.025

Table 1:

GWAS variants nominated for functional causality by MPRAu.

MPRAu Tested SNP tag SNP Gene Trait PMID OR/Beta tamVar log2FC tamVar P value
rs1056801# rs3771570 SEPT2 Prostate cancer 23535732 1.12 −1.2 7.7x10-12
rs1140711 rs10835187 LIN7C Bone mineral density 24945404 0.127 −0.43 0.061
rs12190287# rs12190287 TCF21 Coronary heart disease 21378990 1.08 0.47 0.0021
rs13702# rs10105606 LPL Triglycerides 20864672 0.07 0.31 1.00E-08
rs13702# rs331 LPL HDLC 19936222 1.459 0.31 1.00E-08
rs5891007 rs16887244 LSM1 Schizophrenia 22037555 1.19 0.36 0.004
rs705866# rs7803454 PILRB Age-related macular degeneration 26691988 1.13 0.3 0.083
rs708723 rs823118 RAB7L1 Parkinson’s disease 25064009 1.122 0.37 0.067
rs71396950 rs1805007 SPATA33 Freckles 17952075 4.37 −0.43 0.095
rs71396950 rs1805007 SPATA33 Red hair color 17952075 12.47 −0.43 0.095
rs71396950 rs35063026 SPATA33 Squamous cell carcinoma 26829030 1.33 −0.43 0.095
rs8066731 rs9902453 SLC6A4 Coffee consumption 25288136 0.03 −0.65 0.0039
rs35274349 rs10948363 CD2AP Alzheimer’s disease 24162737 1.1 0.48 6.30E-10

(Most significant adjusted p-value, and its corresponding log2FC, from the MPRAu screen is shown)

#

denotes variant perturbation of a top 100 expressed miRNA,

denotes variant perturbation of a potential RBP motif within an eCLIP-seq peak region.